Anti-Müllerian Hormone

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Anti-Müllerian Hormone trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07339930

Phenotyping of Patients With Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is the leading endocrine disorder of the reproductive system, affecting 10 to 13% of women of childbearing age. However, there…

France100 participantsStarted 2025-09-17

RecruitingNot Applicable

NCT05858307

Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements

This study aims to assess the association of Anti-Müllerian hormone (AMH) with polycystic ovarian syndrome, premature ovarian insufficiency and fertility. The m…

Hong Kong300 participantsStarted 2022-06-22

All recent trials (24 shown)

Not Yet RecruitingNot Applicable

NCT07497191

AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer

This study is a prospective observational cohort study aimed at developing a clinical model based on dynamic changes in anti-Müllerian hormone (AMH) to predict…

Location not specified300 participantsStarted 2026-03-05

By InvitationNot Applicable

NCT07310485

Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausa…

This randomized, double-blind, placebo-controlled clinical trial aims to investigate the effect of flaxseed-derived phytoestrogen supplementation on gene expres…

Jordan70 participantsStarted 2025-11-01

Treatment: SDG lignans, Placebo

Anti-Müllerian Hormone

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Phenotyping of Patients With Polycystic Ovary Syndrome

Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements

All recent trials (24 shown)

AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer

Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausa…

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Phenotyping of Patients With Polycystic Ovary Syndrome

Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements

All recent trials (24 shown)

AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer

Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausa…

Safety and Efficacy of Autologous Adipose-Derived Regenerative Cells (ADRCs) Injection for Improving Diminished Ovarian…

Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density

Associations of Age Measures With Serum Anti-Müllerian Hormone

Pregnancy Prediction Using Anti-Müllerian Hormone in Intrauterine Insemination Cycles

Anti-Müllerian Hormone and Embryo Aneuploidy

Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response

AMH for the Identification of PCOM in PCOS Diagnosis

Measurement of Different Anti-Müllerian Hormone Isoforms in Expected Poor Responders

Anti-Mullerian Hormone - At My Home

Congenital Uterine Anomalies & Pregnancy in Polycystic Ovarian Syndrome

Ovarian Reserve and Ankylosing Spondylitis

Evaluation of HbA1c Levels and Ovarian Reserve and Type 1 Diabetes

Anti-Müllerian Hormone is Not Predictive of Pregnancy in Donor Insemination Cycles in Non-infertile Women

Predictive Value of AMH in IVF; a Prospective RCT

Correlation Between Serum Anti-Müllerian Hormone & Müllerian Ducts Anomalies in Infertility

AMH, Glucose Intolerance and Metabolic Syndrome in PCOS

The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS

The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)